
Cloud Pharmaceuticals uses AI and cloud computing for efficient, cost-effective drug design and development, targeting hard-to-drug indications.
Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. We use a proprietary design process that combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs that are well-qualified for development from the outset and have original composition of matter IP.
The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. Our approach amplifies the power of cloud computing and AI to radically improve drug discovery and design. We partner at all stages of drug development – from discovery through the clinic – and are building an extensive product pipeline that spans a wide range of indications.

XtalPi
xtalpi.com

Drug Design Methodologies
newdrugdesign.com

Valo Health
valohealth.com

Model Medicines
modelmedicines.com

Enable Medicine
enablemedicine.com

PathDrugomics

Polarisqb
polarisqb.com

Pathos AI
pathos.com

Iambic Therapeutics
iambic.ai

Numerion Labs
numerionlabs.ai

Rasio Therapeutics
rasiotx.com

Collaborations Pharmaceuticals

Regenerative Bio
regen-bio.us

X-37
x37.ai

DeepCure
deepcure.ai
Companies similar to Cloud Pharmaceuticals include XtalPi, Drug Design Methodologies, Valo Health and Model Medicines.
Cloud Pharmaceuticals was founded in 2009.
Cloud Pharmaceuticals' headquarters is located in Durham, NC, US.
Cloud Pharmaceuticals' most recent funding round was for $350k (USD) in February 2016.
As of Feb 9, 2016, Cloud Pharmaceuticals has raised a total of $1.8M (USD).
Cloud Pharmaceuticals has 30 employees as of Feb 5, 2024.